Tagged with Brazil

Brazil More than half of the top 20 pharma companies in Brazil are domestic, with Ache, EMS Farma, and Eurofarma taking the top three spots. Ranking is based on MAT December 2018.   Made with Visme Infographic Maker

Saudi Arabia Saudi Arabia is aiming to become a more attractive investment destination for multinational pharma companies through economic development projects that facilitate ease of doing business. Not stopping there, the Kingdom has a bold ambition to become a pharma hub for the entire Middle East region.    Saudi Arabia has the…

Brazil Swiss pharma giant Novartis is teaming up with the Oswaldo Cruz Foundation (Fiocruz) in Brazil to conduct research throughout Latin America on neglected diseases.   This agreement establishes an exchange of know-how that will provide progress in public health policies in Brazil Patrice Matchaba, global head of corporate responsibility, Novartis…

Brazil Three seasoned pharma executives with a wealth of experience working in Brazil offer their insights on leadership strategies for success in the massive, but complex, Brazilian pharma market.          Only a 100 percent ethical business is the right business to be conducted. Pius Hornstein, Country Chair, Sanofi…

Brazil Rodrigo Araujo of global organizational consulting firm Korn Ferry outlines what he sees as the leadership profile of the future – agile, digital, self-aware, and able to transform both themselves and their organizations.   What are the qualities you look for in a Country Manager? Capable leaders are those who…

Brazil The Top 20 pharma companies in Brazil for 2017, combining the data for both the retail and non-retail markets. Sanofi leads the way, followed by local player NC Farma and Hypermarcas.

Brazil The Latin American pharmaceutical market in comparison. Brazil is by far the largest market. GDP real growth in Latin America regional comparison. Top 20 pharma companies in Latin America. Sanofi leads the way followed by Novartis and GSK. Brazil GDP and pharmaceutical market growth between 2014 and 2017. The evolution…

Brazil When combining the sheer size of Brazil – the fifth largest country in the world – with its tropical climate, its largely perfectible infrastructure, and the soaring importance of temperature sensitive biologicals, one understands the urgent need to develop solutions guaranteeing appropriate transport conditions in Brazil. “We may be vaguely…

Canada Upon opening an R&D center in Mississauga in 2017, Biolab Pharma Canada, headed by Paulo Wickbold Marques, became the first Brazilian pharmaceutical company to establish an affiliate in Canada. In this interview, Paulo describes Biolab’s bold leap from Latin America, the strengths of the Canadian pharmaceutical landscape and how the…

Brazil “Brazil undoubtedly holds great development opportunities for the global pharmaceutical and healthcare industries,” boldly states Minister of Health Ricardo Barros, “and we hope to gain the trust of an increasing number of international investors and jointly work on improving the healthcare products and services available to our 207 million Brazilian…

Brazil Maria del Pilar Muñoz, vice-president in charge of M&A and Sustainability at Eurofarma, one of the largest and most innovative pharmaceutical companies in Brazil with operations in 20 countries across Latin Americ , provides insights into the key competitive advantages of Eurofarma, its unique internationalization strategy, and the company’s historical…

Brazil Luciano Marques, president of Alcon Brazil, provides insights into recent investments and innovative initiatives aimed at strengthening Alcon’s relationships with its partners and customers in Brazil, and also documents the heightening of the affiliate’s market access and medical affairs capacities and explains how these aspects have contributed to drive the…